Resovist® is an organ-specific MRI contrast agent, used for the detection and characterization of especially small focal liver lesions.
Resovist® consists of superparamagnetic iron oxide (SPIO) nanoparticles coated with carboxydextran, which are accumulated by phagocytosis in cells of the reticuloendothelial system (RES) of the liver. The uptake of Resovist® Injection in the reticuloendothelial cells results in a decrease of the signal intensity of normal liver parenchyma on both T2- and T1 weighted images.
Most malignant liver tumors do not contain RES cells and therefore do not uptake the iron particles. The resulting imaging effect is an improved contrast between the tumor (bright) and the surrounding tissue (dark).
Resovist® can be injected as an intravenous bolus, which allows immediate imaging of the liver and reduces the overall examination time. A dynamic imaging strategy after bolus injection supports to characterize lesions. In comprehensive clinical trials, it demonstrated an excellent safety profile.
In 2001, Resovist® was approved for the European market.

See also Superparamagnetic Iron Oxide.

Resovist® competed with Primovist™, the other liver imaging agent of Bayer Schering Pharma AG. Due to this reason, the production of Resovist® has been abandoned in 2009.

From GE Healthcare;
The Signa HDx MRI system is GE's leading edge whole body magnetic resonance scanner designed to support high resolution, high signal to noise ratio, and short scan times.
Signa HDx 3.0T offers new technologies like ultra-fast image reconstruction through the new XVRE recon engine, advancements in parallel imaging algorithms and the broadest range of premium applications. The HD applications, PROPELLER (high-quality brain imaging extremely resistant to motion artifacts), TRICKS (contrast-enhanced angiographic vascular lower leg imaging), VIBRANT (for breast MRI), LAVA (high resolution liver imaging with shorter breath holds and better organ coverage) and MR Echo (high-definition cardiac images in real time) offer unique capabilities.

From GE Healthcare;
the New Signa Profile/i is a patient friendly open MRI system that virtually eliminates patient anxiety and claustrophobia, without compromising diagnostic utility.

(SEMS) This pulse sequence is composed of a 90° RF pulse followed by a 180° refocusing pulse. Both RF pulses are applied in the presence of a slice select gradient.
By choosing of different TR and TE, depending on the T1 and T2 values of the tissues, proton density, T1 weighted and T2 weighted images can be acquired.
The inversion recovery option enlarge the RF pulses with a 180° inverting pulse, applied a TI time before the beginning of the pulse sequence in order to manipulate image contrast.
See also Spin Echo Sequence.

A method used to trace the motion or flow of tissue. Nuclei will retain their magnetic orientation for a time on the order of T1 even in the presence of motion. Thus, if the nuclei in a given region have their spin orientation changed, the altered spins will serve as a 'tag' to trace the motion for a time on the order of T1 of any fluid that may have been in the tagged region.